MC
Matrix Capital Management
GeneralistWaltham, United States
Stage FocusSeries A, Series B+
GeographyUS
TypeHedge Fund
Last Activity2024
Industry Focus
Industries
SemiconductorsAI InfrastructureBiotech
Technical BenchStrong
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Matrix Capital Management is a hedge fund founded in 1999 by David Goel, based in Waltham, Massachusetts, managing $5B in AUM as of March 2025 for just 4 clients. In August 2024, Goel announced the fund's closure due to health issues.
The investment approach was a concentrated portfolio of long/short positions primarily in public equities, with a portion allocated to private companies. Focus area...
Notable Investments
M
Maze TherapeuticsSimilar Funds
Samsung Venture Investment Corporation
Seoul, South Korea
GeneralistSemiconductorsBiotechAI InfrastructureSeedSeries A
ams OSRAM Ventures
Munich, Germany
GeneralistSemiconductorsAI InfrastructureBiotechSeedSeries A
Celesta Capital
Silicon Valley, United States
DeepTech NativeSemiconductorsAI InfrastructureAdvanced MaterialsSeries ASeries B+
Giza Venture Capital
Tel Aviv, Israel
DeepTech NativeSemiconductorsAI InfrastructureBiotechSeedSeries A
Intel Capital
Santa Clara, United States
GeneralistSemiconductorsAI InfrastructureQuantum ComputingSeedSeries A
Qualcomm Ventures
San Diego, United States
GeneralistSemiconductorsAI InfrastructureIoT & EdgeSeedSeries A